Thrombosis Resource Center Editorial Programs

 
 
  • NOACs for Preventing Stroke in AF An elderly woman presents with AF in the setting of heart failure. How would you manage her anticoagulation?
  • Reversal Agents for DOACs: When Should You Use Them?   Drs Ruff, Hylek, and Pollack discuss how to manage bleeding associated with direct oral anticoagulants (DOACs, NOACs), when to use reversal agents, and the controversy of restarting anticoagulation.
  • Vasculitis: Overview Video   This video covers the pathophysiology of vasculitis in general, as well as more specific conditions like giant cell arteritis, Takayasu arteritis, Kawasaki disease, polyarteritis nodosa, and others.
  • Apple Watch ECG: Helpful or Headache?   The new ECG feature on the Apple Watch has Michelle O'Donoghue, MD, wondering whether technology is outpacing our ability to interpret and analyze resulting data.
  • A 55-Year-Old Woman Short of Breath: USMLE Question A 55-year-old woman presents with shortness of breath. She has a history of deep vein thrombosis and current breast cancer. What's the next step in management?
  • Dual vs Triple Antithrombotic Therapy? The Debate Continues   Is a NOAC plus an antiplatelet drug enough to prevent thromboses? Stroke? What doses and combinations are safest? Christian Ruff, Mike Gibson, and Chris Cannon examine the evidence.
  • Prevention of Stroke in Obese Patients With Nonvalvular AF Which anticoagulant is most appropriate for stroke prevention in a patient with comorbid obesity and AF? Take this quiz created by experts at ACC to find out.
  • The Only Treatment for Idiopathic Recurrent Pregnancy Loss Dr Peter Kovacs comments on a meta-analysis that concludes that when no cause can be found, only one treatment for recurrent pregnancy loss is supported by the evidence.
  • COMMANDER HF: What Now for Anticoagulation in Heart Failure?   Drs Ileana Piña and Mandeep Mehra discuss the neutral results of the COMMANDER HF trial on rivaroxaban in patients with heart failure in sinus rhythm.
  • ESC 2018Don't Ignore the Many Lessons of the MitraClip Failure Reflecting on the MITRA-FR trial, Dr John Mandrola says it can help us learn both specific lessons about the treatment of people with heart failure and more general lessons on the acceptance of untested therapeutics.
  • An Overlooked Risk Factor for Venous Thromboembolism?   A new meta-analysis identifies a drug class that's linked with thromboembolism.
  • Mandrola's ESC 2018 Preview From aspirin to VTE, John Mandrola reflects on the potpourri of relevant data for the practicing clinician at this year's European Society of Cardiology Congress.
  • When Do We Need RCTs, and When Can We Manage Without Them? A recent debate on Twitter over the use of inferior vena cava filters reinforces the value of conducting randomized controlled trials in medicine, argues Dr Vinay Prasad.
  • The Woman With Multiple Sclerosis and Blurry Vision Why is this 65-year-old patient with relapsing-remitting MS having decreased vision in her right eye?
  • AAN 2018A Computer Algorithm That Guides Stroke Care   Dr Mark Alberts discusses the benefits of using a CT profusion computer algorithm to identify patients with ischemic stroke who are candidates for thrombectomy.
  • 'Time Is Brain': How Mobile Stroke Units Are Saving Lives Medscape spoke with Dr Andrei V. Alexandrov about mobile stroke units with state-of-the-art CT scanners capable of full CT angiography in the field, and how they are changing stroke care.
  • Echo Case: Possibly an All-Time Record Case of…   One of the worst cases Dr Wharton has seen. Can you decipher from the M-modes alone as the echocardiographers of old had to?
  • An 'Incredible' New Wave in Neurology Care   Drs Andrew Wilner and Terry Detrich discuss exciting clinical trial results presented at the 2018 AAN meeting in Los Angeles, and reflect on past breakthroughs in patient care.
  • HRS 2018CABANA in Context: A Nuanced Understanding of AF Ablation   Ablation or medical therapy for atrial fibrillation? Drs Hylek, Piccini, and Ruff describe the finer points of the CABANA trial, presented at the 2018 Heart Rhythm Scientific Sessions.
  • HRS 2018What Is the Role of Ablation for AF in a Post-CABANA World?   Electrophysiologists John Mandrola and Dhiraj Gupta discuss the CABANA trial results and what they mean for catheter ablation of patients with atrial fibrillation.